This document outlines quality control and assurance tests for different dosage forms including tablets, capsules, and creams. For tablets, it discusses tests like disintegration, dissolution, hardness, thickness, and weight variation according to British and United States pharmacopoeia. For capsules, it discusses weight variation, content uniformity, disintegration, and dissolution tests. For creams, it discusses tests like physical appearance, particle size, weight variation, solubility, viscosity, microbial contamination, and assay of active ingredients.
QUALITY CONTROL OF TABLETS IPQC stands for in process quality control. These are checks that are carried out before the manufacturing process is completed.
a) Tablet Weight Variation Test.
b) Tablet hardness Test.
c) Tablet friability Test.
d) Tablet disintegration Test.
e) Tablet dissolution Test.
f) Leakage test of Packaging of tablets / capsules.
g) Capsule weight variation test
h) Determination of Binding Sites and Association constant.
QUALITY CONTROL OF TABLETS IPQC stands for in process quality control. These are checks that are carried out before the manufacturing process is completed.
a) Tablet Weight Variation Test.
b) Tablet hardness Test.
c) Tablet friability Test.
d) Tablet disintegration Test.
e) Tablet dissolution Test.
f) Leakage test of Packaging of tablets / capsules.
g) Capsule weight variation test
h) Determination of Binding Sites and Association constant.
COMPARATIVE EVALUATION OF DIFFERENT PARACETAMOL BRANDSShikha Popali
THE PARACETAMOL TABLETS IS COMMONLY TAKEN AND PRESCRIBED FOR FEVER , SO HERE WE HAVE MADE PRACTICAL IS IT TRUE EVALUATION LABEL AND WHICH BRAND IS MORE SAFE.
IPQC is concerned with providing accurate , specific, & definite descriptions of the procedures to be employed, from, the receipt of raw materials to the release of the finished dosage forms
COMPARATIVE EVALUATION OF DIFFERENT PARACETAMOL BRANDSShikha Popali
THE PARACETAMOL TABLETS IS COMMONLY TAKEN AND PRESCRIBED FOR FEVER , SO HERE WE HAVE MADE PRACTICAL IS IT TRUE EVALUATION LABEL AND WHICH BRAND IS MORE SAFE.
IPQC is concerned with providing accurate , specific, & definite descriptions of the procedures to be employed, from, the receipt of raw materials to the release of the finished dosage forms
Quality Control Tests Of Capsules dosage form.
1. Weight Variation Test
2. Content Uniformity Test
3. Dissolution Test
4. Disintegration Test
5. Leak Test
IPQC Tests for capsules As per IP, BP & USPPramod Ramane
IPQC- In Process Quality Control Tests for Capsules are
1. Uniformity Of Content
2. Disintigration Test
3. Weight Variation Test
4. Dissolution Test
The tests are with Acceptance limits/Criteria as per Indian Pharmacopoeia (IP), British Pharmacopoeia (BP) & United States Pharmacopoeia (USP)
Evaluation of tablets Useful for the Pharmacy Student ... It -contains all the information on how to evaluate the Tablet as per Indian Pharmacopoeia.
Evaluation consist the Procedure of Dissolution.Disintegration,
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
The global radiation oncology market size reached US$ 8.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/radiation-oncology-market
4. OFFICIAL TESTS
BRITISH PHARMACOPOEIA
Gastro resistant tablet:
Disintegration test
Modified release tablet:
Uniformity of weight.
Dispersible tablet:
Disintegration test
Uniformity of dispersion
Uniformity of weight
Uncoated and Coated Tablets:
Disintegration test
Uniformity of weight
UNITED STATE PHARMACOPOEIA
Weight variation
Disintegration
Dissolution
Drug content
5. Tests for tablets
Dissolution tests
Disintegration test
Friability testing
Tablet hardness
Diameter and thickness
Weight variation tests
9. DISINTEGRATION TESTS
Purpose:
To assure product uniformity
Attempts are made to simulate in-
vivo conditions
Actually test does not correlate with
physiological conditions
often done as in process control
13. DISINTEGRATION
TESTING (BP)
TYPES OF TABLETS RANGES
Uncoated 15 min or as per individual monograph
Film coated 30 min or as per individual monograph
Sugar coated 60 min or as per individual monograph
Dispersible tablets 03 min or as per individual monograph
Effervescent tablets 05 min or as per individual monograph
Enteric coated tablets 60 min in buffer :disintegrate
Soluble tablets 03 minutes
17. Procedure:
1. Weigh 20 tab altogether = W1
2. Put these tablets in the friabilator and adjust the instrument
at 100 rpm (i.e. = 25 rpm for 4 min)
3. Weigh the 20 tablets (only the intact ones) = W2
4. Friability (% loss) =
It must be less than or equal to1% but if more we do not
reject the tablets as this test is non-official.
Perform this test using 20 tablets that were used first in the
weight variation test
18.
19. THICKNESS TEST
Checking of thickness and diameter is usually an in-
process control during production
Dimensional specifications of tablets are important
because of many reasons e.g.
1. Packaging requirements
2. Patient compliance
3. Thickness is often related to tablet hardness
Directly affect the assay
Instruments used
• Micrometer
• Vernier calliper
• Now a days digital micrometers are available
20. Specifications for thickness
Limits of thickness depends on tablet weight
• Thickness of majority of tablets varies from 2 mm to 4 mm
depending on diameter of tablet
• A deviation of ± 5% from stated diameter is allowed except
that for exceeding 12.5 mm
For 12.5 mm or above deviation is ± 3%
when the compression of a tablet is increased, its hardness
decreases, but the thickness increases. When the percentage
of active ingredient is increased, the hardness decreases and
the thickness is unaffected. The diameter of the pill remains
relatively unaffected
21. WEIGHT VARIATION
(UNIFORMITY OF WEIGHT)
• Weigh individually 20 whole tablets.
• Calculate average weight.
• Weight of not more than two tablet differ
from the average weight by more than
percentage given in table.
• No tablet differ by more than double the
% age given
23. WEIGHT VARIATION
TOLERANCES FOR
UNCOATED TABLETS IN USP
XVII
AVERAGE WEIGHT OF TABLETS
(mg)
PERCENTAGE DIFFERENCE
130 Or less ± 10.0
From 130 through 324 ± 7.5
More than 324 ±5.0
27. WEIGHT VARIATION
There are two methods for testing uniformity of weight of capsules
Method A
Method B
Method A
• Method A is for capsules with dry contents
• Weigh a capsule, open it without loss of shell material,
remove the contents, and weigh all parts of shell
• The difference between the weights represents the weight of
contents of capsule
• Repeat the operation with further 19 capsules (total 20)
• Capsules pass the test if not more than 2 capsules deviate
from the mean weight by more than percentage given in table
(10 % for 0.120 g or less and 7.5 % for more than 0.120 g)
• For one or two capsules (which are outside above given
range) the weight of content should not more than percentage
given in table below (i.e. 20 % for 0.120 g or less and 15 % for
29. DISINTEGRATION
TIME
BP USP
Hard capsule < 30 min < 30 min
Soft capsule < 60 min < 60 min
Enteric Disintegrate in buffer in 60 min,
Disintegrate in HCL in 2 hours.
NS
Gastro -resistant NS NS
31. ASSAY OF ACTIVE
INGREDIENT (USP)
WEIGHT OF API IN EACH
CAPSULE
SUBTRACT FROM THE LOWER
LIMIT FOR SAMPLE OF
ADD TO THE UPPER LIMIT FOR
SAMPLE OF
15 10 5 15 10 5
0.12 g or less 0.2 0.7 1.5 0.3 0.8 1.8
More than 0.12 g or less than 0.3
g
0.2 0.5 1.2 0.3 0.6 1.5
0.3 g or more 0.1 0.2 0.8 0.2 0.4 1.0
33. PHYSICAL APPEARANCE
The main characteristics need to be checked
are -Cracking of creams (separation of oil and
water) -Development of granular and lumpy
appearance -Marked change in viscosity -
Crystal growth -Microbial contamination
Particle size determination
-Dilute a suitable qty of preparation with equal
volume of glycerol or liquid paraffin, as
specified -Mount on a glass slide and
examine under light microscope -Count the
number of particles with diameter above or
below than that specified in monograph -
Compare the percentage with official limits
34. Weight variation test
-Applies to those products in which labeled net weight is not more
than 150g -Select 10 filled containers, remove the label, clean
and weigh individually -Remove the contents by cutting the
containers and wash with suitable solvent -Dry and again weigh
each empty container together with its corresponding part, take
difference as weight of contents. -The average net weight of
contents of 10 containers should not be less than the labeled
amount -The net weight of contents of any single container
should not be less than 90% of the labeled amount (for ≤ 60g) -
And not less than 95% of the labeled amount (60-150g) -If this
requirement is not met repeat this procedures taking additional
20 containers -The average net weight of contents of 30
containers should not be less than labeled amount -Contents of
not more than 1 of the 30 units should be less than 90% of the
stated amount (for ≤ 60g) -And not less than 95% of the labeled
amount (60-150g)
35. Solubility test -
-The preparation should be soluble in 9 parts of water
and 1.7 parts of hot water -The preparation should be
miscible with alcohol, ether and chloroform
Viscosity determination
Viscosity is determined using a method specified in
official monograph
Microbial contamination
-Microorganisms can grow, if no preservative is added,
or even if added, its efficiency is reduced due to
interaction with other ingredients -Microorganisms may
get into the preparation during handling and storage -
Therefore, aseptic techniques of handling are needed -
Antimicrobial assay should be performed according to
official monograph, usually Direct inoculation method
36. Active ingredients
-Assay of active ingredients should
be performed according to
monograph -Percentage contents
should be within the official limits
37. REFERENCES:
•Remington’s Pharmaceutical Sciences, Mack
Publishing Company , USA, 2001.
•5 Pharmacopoeias B.P, U.S.P, U.S.P/N.F, P.P.
•USP convention inc . The USP 19th rev .,Easton ,
PA., Mack Publishing Company ,1975
•Her Majesty's Stationary Office , BP
1988,Bristol,J.W.,arrowsmith Ltd.
•Pharmaceutical quality assurance in class industry
and market.